Background
==========

Phylogenetically related plant species exhibit phytochemical similarities \[[@B1]\]. For example, taxol is an anti-cancer chemical compound initially isolated from the bark of a rare tree species *Taxus brevifolia*(Pacific Yew tree); however, a closely related and more available species, *Taxus cuspidata*was later proved to be a more commercially viable source for taxol \[[@B2]\]. The growing popularity of Chinese herbal medicine in the United States has prompted large-scale import of raw herbs from Asia \[[@B3]\]. As many Chinese medicinal plants are evolutionarily related to their North American congeners, the North American species may be possible phytochemical substitutes to the Chinese medicinal herbs \[[@B4]\]. For example, North American ginseng (*Panax quinquifolium*) has become the commercial alternative to the rarer Chinese ginseng (*Panax ginseng*) \[[@B5]\]. Growing native substitutes can potentially promote local industry and reduce the ecological risks of cultivating exotic species; however, there is little information available on possible North American phytochemical substitutes to Chinese medicinal herbs.

The present study investigates the alkaloid content in *Coptis trifolia*(American goldthread) and *Hydrastis canadensis*(goldenseal), two herbs found in the United States, and *Coptis chinensis*(*Huanglian*, Chinese goldthread), a Chinese medicinal herb imported from China. The three species belong to the same Ranunculaceae family and have alkaloid rich rhizomes. Phylogenetically related to *Hydrastis canadensis*, the genus *Coptis*has several North American and Asian species \[[@B6]\].

During the 18^th^century, Native Americans used the rhizome of *Coptis trifolia*to treat mouth sores, poor digestion and infections. The species had become scarce due to over harvesting and/or loss of habitat caused by human activities. It was substituted with *Hydrastis canadensis*, which remains available commercially to this date despite the fact that the growth of *Coptis trifolia*has recovered in the northeastern United States \[[@B7]\]. *Hydrastis canadensis*is an \'at risk\' species due to the potential for over harvest but can be cultivated on a small scale \[[@B8]\]. Both species are phylogenetically related to *Coptis chinensis*which is used to treat digestive and respiratory disorders in Chinese medicine \[[@B9]\].

A review of available literature indicates that there has been considerably more pharmacological research on *Coptis chinensis*than *Hydrastis canadensis*and *Coptis trifolia*. Current findings show some of their similarities. Bioassays on *Coptis chinensis*and *Hydrastis canadensis*indicate that both herbs possess anti-microbial activities \[[@B10],[@B11]\]. In addition, *Coptis chinensis*is anti-inflammatory \[[@B12]\] and *Hydrastis canadensis*may improve immune function \[[@B13]\]. Pharmacological studies on *Coptis trifolia*are still lacking. *Coptis chinensis*contains alkaloids such as berberine, palmatine, epiberberine, coptisine, jaterorhizine and columbamine. *Hydrastis canadensis*also contains alkaloids such as berberine, hydrastine, hydrastinine and canadine \[[@B4],[@B14]\]. Isoquiniline alkaloids in *Coptis trifolia*were suggested to be similar to those in *Coptis chinensis*yet they have not been fully characterized \[[@B3]\]. Berberine, a benzylisoquinoline alkaloid, has been found in all three species and has been demonstrated to be anti-carcinogenic and anti-microbial \[[@B15]\].

The present study aims to investigate whether berberine, coptisine, hydrastine and palmatine (major isoquinoline alkaloids) are quantitatively comparable in content among rhizomes of *Hydrastis canadensis, Coptis trifolia*and *Coptis chinensis*.

Methods
=======

*Hydrastis canadensis*(*n*= 20) was obtained from Horizon Herbs, Oregon, USA. *Coptis trifolia*(*n*= 20) was harvested from the Wachmeister field station northern New York, USA. *Coptis chinensis*rhizomes (*n*= 20) were obtained from a supplier in Montreal, Canada. The whole plants of *Hydrastis canadensis*and *Coptis trifolia*were authenticated by comparing their morphology with type specimens at the St Lawrence University herbarium \[[@B16]\]. The *Coptis chinensis*rhizomes were authenticated by comparing the high performance liquid chromatography (HPLC) peaks to those from published data \[[@B17],[@B18]\].

Acetonitrile and methanol (HPLC-grade) were obtained from Pharmco-AAPER (USA). Hexane and phosphoric acid (ACS grade) were obtained from JT Baker (USA). Berberine, palmatine and coptisine were obtained from Sigma-Aldrich (USA) and hydrastine was purchased from MP Biomedical (USA).

All rhizomes of the three herbs were dried at 75°C in a forced air oven for 72 hours and subsequently were ground into fine powder with a mortar and pestle. Alkaloids were extracted with a microwave assisted extraction (MAE) technique \[[@B19]\] and quantified with HPLC \[[@B20]\]. Samples were soaked in 30 mL of extraction solvent. Solvents described by Anderson *et al.*\[[@B21]\] and Li *et al.*\[[@B22]\] were used. Specifically, an extraction solvent of 50:50:0.1 (v/v) hexane-ethanol-phosphoric acid mixture was used for *Hydrastis canadensis*while a 100:0.1 (v/v) methanol-phosphoric acid was used for *Coptis trifolia*and *Coptis chinensis*. These acidified polar solvents effectively extract the isoquinoline alkaloids in their highly soluble, protonated forms. We carried out the method of Li *et al.*\[[@B22]\], except that MAE was employed to shorten the overnight extraction time. The samples were placed in a Aurora MW500 microwave (Aurora Instruments, Canada) programmed to ramp temperature from 25°C to 120°C in four minutes, followed by 90 minutes of extraction at 120°C. Filtered extracts were dried in a Heidolph roto-vaporizer (Heidolph Elektro, Germany) under vacuum of 367 mbar at 70°C and 150 rpm. The dried residue was dissolved in a minimal volume of 100% HPLC-grade acetonitrile, ranging from 400 μl to 2 mL (depending on the residue quantity) for 24 hours.

HPLC analyses were performed according to the validated method of Weber *et al.*\[[@B20]\] on a ThermoSeparations SpectraSYSTEM (Thermo Scientific, USA) chromatograph with an Agilent Eclipse XDB-C18 (4.6 mm × 250 mm × 5 μm) column (Agilent Technologies, USA). The flow rate of the mobile phase, which consisted of 0.2 M ammonium acetate (pH 4.85) and acetonitrile (69:31, v/v), was maintained at 1.0 mL per minute \[[@B20]\] and absorbance was measured at 235 nm and 266 nm. Alkaloids in each sample were identified according to their standard retention times and characteristic A~235~/A~266~ratios. To corroborate alkaloid identity in samples, we used \'spiking tests\' with known standards. Peak area at 266 nm was used to quantify alkaloid content.

Stock solutions were prepared by weighing 5 mg of standard with a Cahn C-35 microbalance (Themo Scientific, USA) into individual 10 mL volumetric flasks and diluting it to volume with water and acetonitrile (10:90 v/v). A 5 mL aliquot of each stock solution was transferred into a 25 mL volumetric flask and diluted to volume with water and acetonitrile (70:30, v/v). Wrapped in aluminum foil and refrigerated, the stock solutions were stable for over two months. Various volumes of standards were analyzed in triplicates to produce standard curves (0.5 to 2 μg). Individual calibration curves, plotted for each alkaloid, were linear (R^2^\> 0.99) over the range of interest.

As the data did not meet the assumption of equal variance, we used non-parametric tests instead of parametric tests for statistical analyses. Kruskal-Wallis test was used to compare Berberine content was compared amongbetween *Hydrastis canadensis*, *Coptis trifolia*and *Coptis chinensis*, whereas Mann-Whitney U test was used to compare coptisine content between *Coptis trifolia*and *Coptis chinensis*.

Results and discussion
======================

Figure [1](#F1){ref-type="fig"} shows the representative chromatograms of the three herbs. Berberine was quantified in all three species. Coptisine was quantified in *Coptis chinensis*and *Coptis trifolia*. Hydrastine and palmatine were unique to *Hydrastis canadensis*and *Coptis chinensis*respectively but absent in *Coptis trifolia*. The Kruskal-Wallis test indicates a significant difference (H = 49.67, *P*\< 0.0001) in berberine content among the three species. *Hydrastis canadensis*has the greatest berberine content, followed by *Coptis chinensis*and *Coptis trifolia*(Table [1](#T1){ref-type="table"}). The Mann-Whitney U test indicates a significant difference (Z = 3.45, *P*\< 0.0001) in the coptisine content in the rhizomes of *Coptis trifolia*and *Coptis chinensis*. *Coptis trifolia*has higher mean coptisine content than that of *Coptis chinensis*.

![**Representative HPLC chromatograms**. (A) *Coptis trifolia.*(B) *Hydrastis canadensis.*(C) *Coptis chinenesis.*All three herbs contain hydrastinine and berberine. Coptisine is present in *Coptis trifolia*and *Coptis chinenesis.*Palmatine is only detected in *Coptis chinensis*, whereas hydrastine is only present in *Hydrastis canadensis.*](1749-8546-4-17-1){#F1}

###### 

Alkaloid content in rhizomes (*n*= 20) of *Hydrastis canadensis, Coptis chinensis*and *Coptis trifolia*(Similar alkaloids differ significantly among species at *P*\< 0.0001.)

  **Species**              **Major alkaloids**   **Mean (SD) alkaloid content (mg/g of rhizome)**
  ------------------------ --------------------- --------------------------------------------------
  *Hydrastis canadensis*   Berberine             16.76 (3.42)
                           Hydrastine            4.81 (1.48)
  *Coptis chinensis*       Berberine             10.60 (1.36)
                           Coptisine             2.35 (0.27)
                           Palmatine             2.91 (0.38)
  *Coptis trifolia*        Berberine             3.80 (1.90)
                           Coptisine             3.44 (1.45)

These results show that *Hydrastis canadensis*is the best source for berberine, whereas *Coptis trifolia*is the best source for coptisine. Neither of the two North American species has all the alkaloids found in their Chinese congener *Coptis chinensis*. *Hydrastis canadensis*and *Coptis trifolia*together contain all the alkaloids found in *Coptis chinensis*except palmatine. Therefore, a combined formulation of the two North American herbs may provide most of the alkaloids in *Coptis chinensis*and may be acceptable to the North American dietary supplements industry if only a few key phytochemicals are required \[[@B23]\]. As growth conditions can influence alkaloid content of a plant, further investigation is indeed needed on how cultivation of the American species may make the substitution possible.

If there is any difference in photochemical content, possible interactions \[[@B24]\], toxicity of the active constituents and the phytochemicals introduced from the American species should be studied. Otherwise, substitution of the Chinese species by the American ones is not recommended.

Conclusion
==========

Neither *Hydrastis canadensis*nor *Coptis trifolia*contains all the alkaloids found in *Coptis chinensis*used in Chinese medicine. Substitutes of this Chinese species by its American relatives are not recommended.
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MAE: microwave assisted extraction; HPLC: high performance liquid chromatography; SD: standard deviation
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